Meeder Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-46
Closed -$6K 2530
2021
Q1
$6K Buy
+46
New +$6K ﹤0.01% 1781
2020
Q2
Sell
-12
Closed -$1K 2126
2020
Q1
$1K Hold
12
﹤0.01% 2172
2019
Q4
$1K Buy
+12
New +$1K ﹤0.01% 2124